EE04261B1 - Aminoadamantaaniühendite kasutamine immunoregulaatoritena - Google Patents

Aminoadamantaaniühendite kasutamine immunoregulaatoritena

Info

Publication number
EE04261B1
EE04261B1 EE9800057A EE9800057A EE04261B1 EE 04261 B1 EE04261 B1 EE 04261B1 EE 9800057 A EE9800057 A EE 9800057A EE 9800057 A EE9800057 A EE 9800057A EE 04261 B1 EE04261 B1 EE 04261B1
Authority
EE
Estonia
Prior art keywords
aminoadamantane
immunoregulators
compounds
aminoadamantane compounds
neutrophils
Prior art date
Application number
EE9800057A
Other languages
English (en)
Estonian (et)
Other versions
EE9800057A (et
Inventor
F. Elstner Erich
Original Assignee
Merz + Co. Gmbh & Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz + Co. Gmbh & Co. filed Critical Merz + Co. Gmbh & Co.
Publication of EE9800057A publication Critical patent/EE9800057A/xx
Publication of EE04261B1 publication Critical patent/EE04261B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EE9800057A 1995-08-25 1996-08-21 Aminoadamantaaniühendite kasutamine immunoregulaatoritena EE04261B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19531342A DE19531342B4 (de) 1995-08-25 1995-08-25 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren
PCT/EP1996/003678 WO1997007791A1 (en) 1995-08-25 1996-08-21 Use of aminoadamantane compounds as immunoregulators

Publications (2)

Publication Number Publication Date
EE9800057A EE9800057A (et) 1998-08-17
EE04261B1 true EE04261B1 (et) 2004-04-15

Family

ID=7770407

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800057A EE04261B1 (et) 1995-08-25 1996-08-21 Aminoadamantaaniühendite kasutamine immunoregulaatoritena

Country Status (21)

Country Link
US (2) US6172116B1 (zh)
EP (2) EP0845984B1 (zh)
JP (1) JPH11512093A (zh)
KR (1) KR100392986B1 (zh)
CN (1) CN1282452C (zh)
AT (1) ATE234083T1 (zh)
AU (1) AU718219B2 (zh)
CA (1) CA2230159C (zh)
CZ (1) CZ299356B6 (zh)
DE (3) DE19531342B4 (zh)
DK (1) DK0845984T3 (zh)
EE (1) EE04261B1 (zh)
ES (1) ES2193259T3 (zh)
GE (1) GEP19991779B (zh)
IL (1) IL123394A (zh)
MX (1) MX217078B (zh)
NO (1) NO319153B1 (zh)
RU (1) RU2219916C2 (zh)
UA (1) UA57711C2 (zh)
WO (1) WO1997007791A1 (zh)
ZA (1) ZA967137B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60042896D1 (de) * 1999-04-28 2009-10-15 Bellus Health Int Ltd Zusammensetzungen und verfahren zur behandlung von amyloidosis mit sulphonatderivaten
US6444702B1 (en) 2000-02-22 2002-09-03 Neuromolecular, Inc. Aminoadamantane derivatives as therapeutic agents
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
UA79908C2 (en) * 2004-06-24 2007-07-25 Olainfarm Joint Stock Company Application of polymeric salts 3,5-dimethyl-1-adamantilammonium as immunostimulative and interferonogenous agent
WO2006085149A2 (en) 2004-12-22 2006-08-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
DK2089417T3 (en) 2006-10-12 2015-03-23 Bhi Ltd Partnership Methods, Compounds, Compositions and Vehicles for Delivery of 3-Amion-1-Propanesulfonic Acid
US8901316B2 (en) * 2010-08-09 2014-12-02 Shionogi & Co., Ltd. Process for preparing aminoadamantyl carbamate derivatives
CN109922796B (zh) 2016-06-23 2023-04-07 考里安有限责任公司 具有亲水和疏水域的粘合剂基质和治疗剂
US10300025B2 (en) 2016-07-27 2019-05-28 Corium, Inc. Donepezil transdermal delivery system
AU2017301929B2 (en) 2016-07-27 2023-03-02 Corium Pharma Solutions, Inc. Memantine transdermal delivery systems
US10016372B2 (en) 2016-07-27 2018-07-10 Corium International, Inc. Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
WO2019126531A1 (en) 2017-12-20 2019-06-27 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3450761A (en) * 1967-03-30 1969-06-17 Sun Oil Co 1-aminoethyldimethyladamantane
DE4014672A1 (de) * 1990-05-08 1991-11-14 Werner E G Prof Dr Mueller Verwendung von adamantan-derivaten zur zytoprotektion von nicht-infizierten und virus-infizierten lymphozyten als auch anderen zelltypen

Also Published As

Publication number Publication date
AU718219B2 (en) 2000-04-13
DE19531342A1 (de) 1997-02-27
CA2230159A1 (en) 1997-03-06
DE69626650D1 (de) 2003-04-17
EP0845984A1 (en) 1998-06-10
DE69626650T2 (de) 2003-12-18
NO980793D0 (no) 1998-02-25
CZ52498A3 (cs) 1999-04-14
DK0845984T3 (da) 2003-06-23
NO319153B1 (no) 2005-06-27
WO1997007791A1 (en) 1997-03-06
DE10399029I1 (de) 2004-01-08
EP1293201A3 (en) 2003-05-21
US6255348B1 (en) 2001-07-03
MX217078B (es) 2003-10-22
UA57711C2 (uk) 2003-07-15
RU2219916C2 (ru) 2003-12-27
KR100392986B1 (ko) 2003-11-17
AU6926396A (en) 1997-03-19
NO980793L (no) 1998-02-25
GEP19991779B (en) 1999-10-05
DE19531342B4 (de) 2007-11-29
EP1293201A2 (en) 2003-03-19
US6172116B1 (en) 2001-01-09
EE9800057A (et) 1998-08-17
CN1198669A (zh) 1998-11-11
CZ299356B6 (cs) 2008-07-02
ATE234083T1 (de) 2003-03-15
CN1282452C (zh) 2006-11-01
IL123394A0 (en) 1998-09-24
ZA967137B (en) 1997-03-12
MX9801496A (es) 1998-05-31
IL123394A (en) 2004-07-25
CA2230159C (en) 2008-02-26
EP0845984B1 (en) 2003-03-12
JPH11512093A (ja) 1999-10-19
KR19990044096A (ko) 1999-06-25
ES2193259T3 (es) 2003-11-01

Similar Documents

Publication Publication Date Title
RU94041950A (ru) Использование соединений ряда 3-аролоксипропиламинов в лечении недержания
RU94038043A (ru) Применение замещенных производных аденина для лечения множественного склероза
EE04261B1 (et) Aminoadamantaaniühendite kasutamine immunoregulaatoritena
AU1373499A (en) Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease
NZ251320A (en) Bis-aromatic alpha,beta-unsaturated ketones, preparation and use in pharmaceutical compositions
BR9708468A (pt) Tratamento de fotoferese de leucocitos.
DE59310085D1 (de) Indolocarbazol-imide und deren verwendung
HU910681D0 (en) Medical solution
DE69229442D1 (de) Substituierte dibenzooxazepin-verbindungen, pharmazeutische zusammensetzungen und verfahren zur verwendung
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
WO2003013424A3 (en) Use of r-nsaid compounds for anti-hiv treatment
ATE114154T1 (de) Thienotriazolodiazepine und ihre pharmazeutische verwendung.
DE68926972D1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische Anwendungen
IT1245717B (it) Composto farmaceutico a base di un antocianidina per il trattamento di malattie oftalmiche
FI860816A (fi) Menetelmä terapeuttisesti käyttökelpoisten polyprenyyliyhdisteiden valmistamiseksi
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
SE9700244D0 (sv) Novel antibacterial protein
NZ335057A (en) Pentaerythritol derivatives, their production and use and intermediates for their synthesis
ATE145911T1 (de) Inositol-phosphat-analog als kalzium- antagonistische substanz
OA09197A (fr) "Peptides SDK, leur procédé de préparation ainsi que des compositions thérapeutiques en contenant".
TH24203A (th) อนุพันธ์ของออพทิคัลลี แอคทีฟ เบนโซไชอีพิน การเตรียมและการใช้ประโยชน์ของสารเหล่านี้
ES2037825T3 (es) Uso farmaceutico de tioeteres aromaticos.
DK653687A (da) Middel til behandling af nyresygdomme
TH50173A (th) การใช้ 1-ไฮดรอกซี-2-ไพริโดนสำหรับการบำบัดการติดเชื้อที่ผิวหนัง
ID21321A (id) Senyawa-senyawa betha-laktam untuk pengobatan penyakit infeksi disebabkan mikroorganisme penghasil betha-laktamase

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20080821